Implantable cardioverter defibrillator (ICD) is recommended for patients with ventricular tachycardia (VT) due to cardiac sarcoidosis (CS). Programming supraventricular tachycardia (SVT) discriminators (onset, stability, and morphology/template match) is generally recommended to minimize inappropriate therapies. However, VT in patients with CS is known to show cycle length variability (CLV) and pleomorphism.

中文翻译：

---

由于具有 ICD 的心脏结节病患者的周期长度变化而导致 VT 诊断不足：稳定性鉴别器的问题。

对于因心脏结节病 (CS) 引起的室性心动过速 (VT) 的患者，建议使用植入式心律转复除颤器 (ICD)。通常建议对室上性心动过速 (SVT) 鉴别器（发作、稳定性和形态/模板匹配）进行编程，以尽量减少不适当的治疗。然而，已知 CS 患者的 VT 表现出周期长度变异性 (CLV) 和多形性。